hotspot -WSS

hotspot

author：comprehensive 2025-09-07 14:03:39 - browse：91

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Plastic surgeons increase patient psychiatric screenings

knowledge

WSS

Physicians and social media: If you see something, say something?

What the Wegovy shortage looks like for doctors — and for patients

A revolution in caring for preterm infants

Readout LOUD podcast: Merger Mondays, Ozempic panic

Cancer cells are shown to suck energy source from immune cells

Methadone treatment changes are coming. Do they go far enough?

hotspot

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Gene editing the human germline: What are the risks?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How should state employee insurance handle Wegovy?

Novavax promises a turnaround & Lilly roils the obesity market

Eight reasons why you should get an updated Covid vaccine

Medical leaders decry Supreme Court decision on affirmative action

Neuroscience’s long legacy of racism

Continuity nursing helped my family in our darkest PICU moments

What the Wegovy shortage looks like for doctors — and for patients

knowledge

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Medicare to cover more brain scans related to Alzheimer’s drugs

Takeaways from AdvaMed, the largest medical devices conference

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

U.K. researchers warn about biases in medical devices, algorithms

Bernie Sanders bashes nonprofit hospitals over their tax breaks

knowledge

Wikipedia

entertainment

leisure time